Episode Player
Consolidation Versus Independence in Cancer Care
AVBCC Value-Based Voices
Chapters
0:00
Introduction to the episode and guest
1:01
Clarifying consolidation and independence in oncology
2:14
Distinguishing One Oncology from roll-ups and private equity
3:13
The role of capital in practice growth and diversification
4:13
Market share, consolidation, and community options
5:27
Transitioning practices from hospital to community settings
7:23
Policy pressures and the need for scale in healthcare
8:34
The importance of leveling the playing field in healthcare
9:13
Future of value-based care in oncology
10:38
Future of value-based care in oncology
12:03
Early adoption of cell and gene therapies in the community
14:19
Community engagement in clinical trials and therapy adoption
16:36
The importance of data and analytics in oncology
22:07
Challenges in seamless data sharing and diagnostics
23:21
The impact of incentives and misaligned policies
24:21
Closing remarks and future outlook
AVBCC Value-Based Voices
Consolidation Versus Independence in Cancer Care
Feb 24, 2026
Season 1
Episode 3
Rachael
Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits?
In this episode of Value-Based Voices Sarah Alwardt, PhD, President, Avalere Health, and Jeff Patton, MD, CEO, OneOncology, discuss the nuances of consolidation versus independence in cancer care, the impact of policy and capital access, and the future of value-based oncology. Gain insights into sustainable models, data utilization, and patient-centered strategies.
Contact Value-Based Voices
- Follow AVBCC on LinkedIn
- View our podcast lineup
- Contact us at info@avbcc.org
Thanks for listening!
